Shelter Pharma Ltd

Shelter Pharma Capital Structure Change

Shelter Pharma Limited approved the conversion of 2,79,000 warrants into 1,14,000 equity shares at its Board Meeting on May 01, 2026. The company received ₹0.36 Crore as the remaining 75% exercise price from three non-promoter investors. This conversion increases the company's paid-up equity share capital to ₹16.73 Crore.

Value

₹0.36 Cr

Shelter Pharma Bags ₹0.98 Cr Order

Shelter Pharma Limited has received an international purchase order worth USD 103,950 (approx. ₹0.98 Crore) from Taha Drugs & Chemicals Co. Ltd. for 189,000 boxes of 'All Vitamins' tablets. This order marks a significant milestone in the company's global expansion and revenue growth journey.

Value

₹0.98 Cr

Execution

Mutually agreed timelines as per purchase order and shipment schedule

Shelter Pharma Bags ₹1.35 Cr Order

Shelter Pharma Limited secured an international order worth $1,44,000 (₹1.35 Crore) from Sudan-based Taha Drugs & Chemicals Co. Ltd. The contract involves supplying Joemega Capsules and All Vitamins tablets within two months. This noteworthy export order enhances the company's international footprint in the nutraceutical market.

Value

₹1.35 Cr

Execution

Within 2 Months

Shelter Pharma Business Update

Shelter Pharma Ltd has commenced product exports to Sudan, including its daily multivitamin 'Allvitamin'. This move is part of the company's regular international supply operations to African markets, aimed at strengthening its global presence and diversifying revenue streams through consistent international supply relationships.

Execution

ongoing

Shelter Pharma Management Change

Shelter Pharma Limited has appointed key senior management personnel, including Mr. Javed as Zonal Sales Manager and Mr. Ashok Chauhan as Regional Sales Manager. These appointments aim to strengthen the sales and export structure to support business expansion and international growth. No financial considerations were disclosed in the announcement.

Shelter Pharma Other Announcement

Shelter Pharma Limited informed the exchange that the Annual Secretarial Compliance Report under Regulation 24A is not applicable to the company. As an entity listed on the BSE SME platform, it is exempt from certain SEBI LODR provisions. This is a routine regulatory clarification for investors.

Shelter Pharma Capacity Expansion

Shelter Pharma Ltd has initiated a structured hiring process for senior management roles, including Zonal, Area, and Export Heads. This expansion of the leadership team aligns with the company's strategic domestic growth plans and aims to enhance operational efficiency and long-term business performance.

Shelter Pharma Announces New Order Win

Shelter Pharma Ltd has qualified the technical evaluation stage for a veterinary medicine supply tender from Verka Dairies. The company has been invited to a negotiation meeting to finalize contract terms. This development underscores the firm's growing credibility in the veterinary healthcare segment; final contract details will be disclosed in due course.

Execution

To be determined post finalization